Cargando…
Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19
Introduction Hypercoagulability is a hallmark of COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2).(1) While studies have investigated vascular thromboembolic events (VaTE) in critically ill and hospitalized patients with COVID-19, less is known about t...
Autores principales: | Eswaran, Harish, Jarmul, Jamie, Shaheen, Amy, Meaux, David, Long, Tristan, Saccoccio, Derek, Moll, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330154/ http://dx.doi.org/10.1182/blood-2020-140063 |
Ejemplares similares
-
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
por: Eswaran, Harish, et al.
Publicado: (2021) -
Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021) -
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry
por: Li, Ang, et al.
Publicado: (2020) -
Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021) -
Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2019)